Portman Square Capital’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-10,457	Closed	-$1.44M	–	120
2024 Q2	$1.44M	Buy	10,457 +8,800	+531%	+$1.21M	0.05%	37
2024 Q1	$229K	Hold	1,657	–	–	0.01%	82
2023 Q4	$218K	Buy	+1,657	New	+$218K	0.01%	122